Director – Business Development & Acquisitions
AbbVie
Director – Business Development & Acquisitions
AbbVie
Global biopharmaceutical company developing medicines
The Business Development & Acquisitions function drives the advancement of AbbVie’s R&D pipeline and commercial business by assessing and executing key strategic transactions. Example transaction types include in-licensing, out-licensing, co-development / co-promotion, collaboration, and option deals, as well as divestiture / carve-outs and mergers & acquisitions. The Oncology Director of Business Development & Acquisitions, supports those efforts through development of analytical assessments to determine opportunity viability, communication of findings to senior management and participation in terms and contract negotiations for the Oncology Therapeutic Area.
Responsibilities:
Applicable only to applicants applying to a position in any location with pay disclosure requirements under state or local law:
Note: No amount of pay is considered to be wages or compensation until such amount is earned, vested, and determinable. The amount and availability of any bonus, commission, incentive, benefits, or any other form of compensation and benefits that are allocable to a particular employee remains in the Company's sole and absolute discretion unless and until paid and may be modified at the Company’s sole and absolute discretion, consistent with applicable law.
AbbVie is an equal opportunity employer and is committed to operating with integrity, driving innovation, transforming lives and serving our community. Equal Opportunity Employer/Veterans/Disabled.
US & Puerto Rico only - to learn more, visit https://www.abbvie.com/join-us/equal-employment-opportunity-employer.html
US & Puerto Rico applicants seeking a reasonable accommodation, click here to learn more:
https://www.abbvie.com/join-us/reasonable-accommodations.html
Compensation: 182000 to 346000 (USD) (YEARLY)
AbbVie is a global biopharmaceutical company that develops and sells medicines to treat serious health conditions. Its portfolio spans immunology, oncology, virology, neuroscience, and aesthetics, with products designed to modulate the immune system, target disease pathways, or support medical aesthetics. AbbVie compounds its products through a heavy emphasis on research and development, investing billions to build a steady pipeline of new therapies. Its medicines are brought to market by selling to healthcare providers, hospitals, and clinics, and in some cases directly to patients via prescriptions. The company differentiates itself through a wide, globally distributed product line, substantial R&D investment, and a commitment to sustainability and patient care, including science-based targets. AbbVie’s goal is to improve patient outcomes by delivering effective treatments for unmet medical needs while pursuing long-term, responsible growth across healthcare markets.
Explore more opportunities at AbbVie